Antimicrobial peptides and gut microbiota in homeostasis and pathology.

Ostaff, Maureen J et al.·EMBO molecular medicine·2013·
RPEP-022512013RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Antimicrobial peptides and gut microbiota in homeostasis and pathology.
Published In:
EMBO molecular medicine, 5(10), 1465-83 (2013)
Database ID:
RPEP-02251

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-02251·https://rethinkpeptides.com/research/RPEP-02251

APA

Ostaff, Maureen J; Stange, Eduard Friedrich; Wehkamp, Jan. (2013). Antimicrobial peptides and gut microbiota in homeostasis and pathology.. EMBO molecular medicine, 5(10), 1465-83. https://doi.org/10.1002/emmm.201201773

MLA

Ostaff, Maureen J, et al. "Antimicrobial peptides and gut microbiota in homeostasis and pathology.." EMBO molecular medicine, 2013. https://doi.org/10.1002/emmm.201201773

RethinkPeptides

RethinkPeptides Research Database. "Antimicrobial peptides and gut microbiota in homeostasis and..." RPEP-02251. Retrieved from https://rethinkpeptides.com/research/ostaff-2013-antimicrobial-peptides-and-gut

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.